Ribosome biogenesis and ribosome therapy in cancer cells

Q3 Pharmacology, Toxicology and Pharmaceutics Research Results in Pharmacology Pub Date : 2022-10-05 DOI:10.3897/rrpharmacology.8.81706
G. Temaj, R. Hadziselimovic, H. Nefic, N. Nuhii
{"title":"Ribosome biogenesis and ribosome therapy in cancer cells","authors":"G. Temaj, R. Hadziselimovic, H. Nefic, N. Nuhii","doi":"10.3897/rrpharmacology.8.81706","DOIUrl":null,"url":null,"abstract":"Introduction: The process of protein synthesis is a vital process for all kingdoms of life. The ribosome is a ribonucleoprotein complex that reads the genetic code, from messenger RNA (mRNA) to produce proteins and to tightly regulate and ensure cells growth. The fact that numerous diseases are caused by defect during the ribosome biogenesis is important to understand this pathway.\n Materials and methods: We have analyzed the literature for ribosome biogenesis and its links with different diseases which have been found.\n Results and discussion: We have discussed the key aspect of human ribosome biogenesis and its links to diseases. We have also proposed the potential of applying this knowledge to the development of a ribosomal stress-based cancer therapy.\n Conclusion: Major challenges in the future will be to determine factors which play a pivotal role during ribosome biogenesis. Therefore, more anti-cancer drugs and gene therapy for genetic diseases will be developed against ribosomal biogenesis in the coming years.\n Graphical abstract:\n \n \n","PeriodicalId":21030,"journal":{"name":"Research Results in Pharmacology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research Results in Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3897/rrpharmacology.8.81706","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: The process of protein synthesis is a vital process for all kingdoms of life. The ribosome is a ribonucleoprotein complex that reads the genetic code, from messenger RNA (mRNA) to produce proteins and to tightly regulate and ensure cells growth. The fact that numerous diseases are caused by defect during the ribosome biogenesis is important to understand this pathway. Materials and methods: We have analyzed the literature for ribosome biogenesis and its links with different diseases which have been found. Results and discussion: We have discussed the key aspect of human ribosome biogenesis and its links to diseases. We have also proposed the potential of applying this knowledge to the development of a ribosomal stress-based cancer therapy. Conclusion: Major challenges in the future will be to determine factors which play a pivotal role during ribosome biogenesis. Therefore, more anti-cancer drugs and gene therapy for genetic diseases will be developed against ribosomal biogenesis in the coming years. Graphical abstract:
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Ribosome肿瘤细胞的生物发生和核糖体治疗
蛋白质合成的过程是所有生命王国的重要过程。核糖体是一种核糖核蛋白复合物,它读取遗传密码,从信使RNA (mRNA)产生蛋白质,并严格调节和确保细胞生长。许多疾病都是由核糖体生物发生过程中的缺陷引起的,这对理解这一途径具有重要意义。材料和方法:我们对已发现的核糖体生物发生及其与不同疾病的联系进行了文献分析。结果和讨论:我们讨论了人类核糖体生物发生的关键方面及其与疾病的联系。我们还提出了将这些知识应用于基于核糖体应激的癌症治疗的发展的潜力。结论:确定在核糖体生物发生过程中起关键作用的因素将是未来研究的主要挑战。因此,未来将有更多针对核糖体生物发生的抗癌药物和遗传性疾病的基因治疗被开发出来。图形化的简介:
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Research Results in Pharmacology
Research Results in Pharmacology Medicine-Pharmacology (medical)
CiteScore
1.50
自引率
0.00%
发文量
32
审稿时长
12 weeks
期刊最新文献
Исследование влияния полипренолов пихты сибирской на обучаемость и память мышей с экспериментальной моделью болезни Альцгеймера Chemoproteomic analysis of the promising candidate molecule of the indole derivative with lab code SV-1010 and other non-steroidal anti-inflammatory drugs An effective way for targeting EGFR-mediated carcinogenesis: an in vitro study Protective effects of thymogen analogues, modified by D-alanine, in hydrazine liver damage Assessment of VEGF and TNF-alpha levels in patients with an unexpectedly poor and suboptimal response during the treatment of infertility using ART methods
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1